Type III Hyperlipoproteinemia (Dysbetalipoproteinemia)
What is Type III Hyperlipoproteinemia (Dysbetalipoproteinemia)?
Type III hyperlipoproteinemia, also called dysbetalipoproteinemia, is a rare inherited disorder that affects how your body processes fats. People with this condition cannot properly break down certain fat particles in their blood. This leads to a buildup of cholesterol-rich remnants that should normally be cleared away.
The condition is caused by a defect in a protein called apolipoprotein E, or apoE for short. This protein acts like a key that helps fat particles dock at the liver for removal. When apoE does not work correctly, intermediate-density lipoprotein particles, or IDL for short, accumulate in the bloodstream. This raises both cholesterol and triglyceride levels significantly.
Type III hyperlipoproteinemia affects roughly 1 in 10,000 people. It usually appears in adulthood, often after age 20. The condition greatly increases the risk of heart disease and stroke if left untreated. Early detection through blood testing helps you take action before serious problems develop.
Symptoms
- Yellowish fatty deposits under the skin, especially on the palms and elbows
- Yellowish bumps or nodules around the eyes called xanthomas
- Creamy appearance of blood after standing overnight
- Yellowish skin creases on the hands, known as palmar xanthomas
- Chest pain or discomfort from reduced blood flow to the heart
- Leg pain or cramping when walking due to narrowed arteries
- Early development of fatty deposits in arteries
Many people with type III hyperlipoproteinemia have no symptoms in the early stages. The condition often goes unnoticed until a routine blood test reveals abnormal lipid levels. Some people only discover they have it after developing heart disease or other vascular problems.
Concerned about Type III Hyperlipoproteinemia (Dysbetalipoproteinemia)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Type III hyperlipoproteinemia is caused by genetic variations in the APOE gene. Most people with this condition inherit two copies of the apoE2 variant, one from each parent. However, having this genetic pattern alone is not enough to cause the condition. A second trigger is usually needed, such as obesity, diabetes, low thyroid function, or hormonal changes. This explains why symptoms often appear in middle age rather than childhood.
Risk factors that can unmask or worsen the condition include being overweight, eating a diet high in saturated fats, having poorly managed diabetes, untreated low thyroid function, and taking certain medications. Men typically develop symptoms earlier than women. Women often show signs after menopause when estrogen levels drop. Family history of early heart disease or unusual cholesterol patterns also increases your risk.
How it's diagnosed
Doctors diagnose type III hyperlipoproteinemia through blood tests that measure your lipid levels. A lipid panel will show elevated total cholesterol and triglycerides, often in roughly equal amounts. The key diagnostic clue is an elevated VLDL cholesterol level with an abnormal ratio to triglycerides. When VLDL cholesterol divided by triglycerides is greater than 0.3, this suggests type III hyperlipoproteinemia.
Rite Aid offers testing that includes VLDL cholesterol measurement as part of our flagship panel. This can help identify the characteristic pattern seen in this condition. Your doctor may also order genetic testing to confirm the apoE2 variant. Additional tests may check for secondary causes like thyroid disease or diabetes. Getting tested regularly helps catch abnormal patterns early.
Treatment options
- Follow a diet low in saturated fats, trans fats, and cholesterol to reduce lipid levels
- Achieve and maintain a healthy weight through portion control and regular eating patterns
- Exercise regularly, aiming for at least 150 minutes of moderate activity per week
- Avoid or limit alcohol consumption, which can raise triglyceride levels
- Take fibrate medications like gemfibrozil or fenofibrate as prescribed by your doctor
- Use statin medications in combination with fibrates for some patients
- Treat underlying conditions like diabetes or low thyroid function that worsen lipid levels
- Monitor lipid levels regularly to track treatment response and adjust therapy as needed
- Work with a registered dietitian to create a personalized eating plan
- Quit smoking to reduce cardiovascular risk and improve overall vascular health
Concerned about Type III Hyperlipoproteinemia (Dysbetalipoproteinemia)? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Type III hyperlipoproteinemia causes a unique pattern where both cholesterol and triglycerides are elevated in roughly equal amounts. The condition results from defective apoE protein, which prevents proper clearance of IDL particles. This creates a characteristic abnormal ratio of VLDL cholesterol to triglycerides. Unlike other lipid disorders, it often causes distinctive yellowish skin deposits on the palms and elbows.
Type III hyperlipoproteinemia is rare, affecting about 1 in 10,000 people. While many people inherit the apoE2 genetic variant, only a small percentage develop the full condition. A secondary trigger like obesity or diabetes is usually needed to unmask the disorder. The rarity means it is sometimes overlooked or misdiagnosed as more common lipid problems.
Type III hyperlipoproteinemia cannot be cured because it is a genetic condition. However, it can be managed very effectively with lifestyle changes and medication. Many people achieve normal or near-normal lipid levels with treatment. The key is early detection, consistent treatment, and regular monitoring to prevent complications.
Palmar xanthomas are yellowish deposits of cholesterol that appear in the creases of your palms. They occur when excess lipids accumulate under the skin due to high cholesterol levels. These deposits are highly characteristic of type III hyperlipoproteinemia. They often disappear or shrink significantly once lipid levels are controlled with treatment.
Blood tests typically show elevated total cholesterol and triglycerides in roughly equal amounts. The diagnostic key is an elevated VLDL cholesterol with an abnormal ratio to triglycerides, usually greater than 0.3. Your doctor may also see elevated IDL particles on specialized testing. These patterns together point toward type III hyperlipoproteinemia rather than other lipid disorders.
Diet plays a crucial role in managing type III hyperlipoproteinemia. Reducing saturated fats, trans fats, and dietary cholesterol helps lower lipid levels significantly. A low-fat diet rich in vegetables, fruits, and whole grains supports treatment. Many people see dramatic improvements in their cholesterol and triglyceride levels with dietary changes alone, though medication is often still needed.
Fibrate medications like gemfibrozil and fenofibrate are the first-line treatment for type III hyperlipoproteinemia. These drugs are particularly effective at lowering triglycerides and remnant lipoproteins. Some patients also need statins to further reduce cholesterol levels. Your doctor will choose medications based on your specific lipid pattern and other health factors.
Yes, type III hyperlipoproteinemia significantly increases the risk of early heart disease and stroke. The accumulated lipid particles promote fatty buildup in arteries throughout the body. This can lead to coronary artery disease, peripheral artery disease, and stroke. Early detection and treatment greatly reduce these risks and protect your cardiovascular health.
Genetic testing for the apoE variant can confirm the diagnosis but is not always necessary. Many doctors diagnose the condition based on characteristic blood lipid patterns and physical findings. Genetic testing may be helpful if the diagnosis is unclear or to screen family members. Your lipid profile and VLDL cholesterol ratio often provide enough information to start treatment.
Yes, family members should consider lipid screening because the condition is inherited. If you have type III hyperlipoproteinemia, your siblings and children may carry the apoE2 variant. Early detection in relatives allows for preventive measures before symptoms develop. A simple lipid panel and VLDL cholesterol test can identify at-risk family members who would benefit from monitoring.